The final report of the TOGETHER Trial, published in March 2022 in the New England Journal of Medicine, has major discrepancies in the data compared with what was published by the media more than six months earlier in addition to serious methodological inconsistencies that must be brought to light. Despite numerous requests by international scientists to address these issues, none has been forthcoming
Probable Scientific Misconduct Uncovered
- The manager of the International COVID-19 Data Alliance (ICODA) confirmed that its website, to which the TOGETHER trial has been directing inquiries for deidentified patient data, never actually hosted the study's data.
- Dr. David Scheim, Dr. Edmund Fordham, and Professor Colleen Aldous have sent a letter requesting that the data be made available immediately or to retract the paper.
Call for Action
- This is not the first time that attempts have been made to manipulate data and scientific manuscripts to undermine the evidence that shows ivermectin is effective against Covid-19.
- The World Council for Health urges journalists, scientists, and civil society to focus due attention on TOGETHER Trial investigators so that they reveal what has been hidden.
Letter to TOGETHER Trial authors, the NEJM Editor-in-Chief, and others
- In a breaking development, it has been revealed that the toGETHER trial has misdirected inquiries to a web repository that never hosted its data, thereby denying the scientific community access to the underlying data for its ivermectin arm since the study's publication on March 30, 2022.
- The four outcome measures that scientists have repeatedly requested since April 11, comparative per protocol death and hospitalization rates, treatment vs. placebo, should be disclosed immediately.
No comments:
Post a Comment